You are here

Harbour BioMed

Harbour BioMed launches new obesity biotech on mission to preserve muscle mass

Fierce Biotech

Wed, 03/12/25 - 11:21 am

bispecific antibodies

Élancé Therapeutics

AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies

Fierce Biotech

Thu, 05/23/24 - 10:47 am

Nona Biosciences

FDA grants clearance to Harbour’s IND for solid tumors therapy trial

Clinical Trials Arena

Mon, 08/28/23 - 11:58 am

clinical trials

Harbour reports results from HCC combo therapy trial

Clinical Trials Arena

Mon, 05/29/23 - 12:23 pm

hepatocellular carcinoma

clinlcal trials

Harbour BioMed, Moderna partner on immunotherapies development

Pharmaceutical Business Review

Fri, 11/11/22 - 10:34 am

Nana Biosciences

Moderna Therapeutics

immunotherapies

AstraZeneca bets $25M on preclinical bispecific against hot target, docking in Chinese Harbour to land global rights

Fierce Biotech

Thu, 04/7/22 - 11:16 am

AbbVie's Covid-19 antibody partner wraps $221M Hong Kong IPO

Endpoints

Thu, 12/17/20 - 11:05 am